Inventor
LIM NGIAP KIE
US19 patents
⚠️ This page may combine multiple inventors who share the name “LIM NGIAP KIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
10 patentsUS10954234B2Mar 23, 2021
Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use
GENENTECH INC6 citations80
US11661424B2May 30, 2023
Process for preparing BTK inhibitors
GENENTECH INC1 citations70
US10882864B2Jan 5, 2021
Process for preparing BTK inhibitors
GENENTECH INC3 citations70
US10385058B2Aug 20, 2019
Process for preparing BTK inhibitors
GENENTECH INC3 citations70
US11702452B2Jul 18, 2023
Process for making arylomycin ring analogs
GENENTECH INC0 citations55
US11192924B2Dec 7, 2021
Process for making arylomycin ring analogs
GENENTECH INC0 citations55
US9969735B2May 15, 2018
Process for making tricyclic lactam compounds
GENENTECH INC0 citations51
US9975856B2May 22, 2018
Process for the preparation of (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid
GENENTECH INC0 citations47
US12172982B2Dec 24, 2024
Synthesis of quinazoline compounds
GENENTECH INC0 citations41
US12071422B2Aug 27, 2024
Process for synthesis of quinazoline compounds
GENENTECH INC0 citations41
SCHERING CORP
3 patentsUS7605275B2Oct 20, 2009
Exo- and diastereo- selective syntheses of himbacine analogs
SCHERING CORP12 citations82
US7772276B2Aug 10, 2010
Exo-selective synthesis of himbacine analogs
SCHERING CORP0 citations51
US7989653B2Aug 2, 2011
Exo- and diastereo-selective syntheses of himbacine analogs
SCHERING CORP0 citations49